February sees some vitally important issues on the European Commission’s agenda, including areas where the sector has been clamouring for progress in terms of clarity over the Commissions’ thinking and guidance documents. Overall 2020 meetings are plentiful and critical.

Once the world's factory, China has seen costs inch up while drug prices are being cut deeply by centralized procurement schemes. As uncertainties mount, companies need to focus on improving process and scale-up technology, suggested industry observers at a JPM panel discussion on innovation and market access challenges.